Compugen, Inc.
Compugen, Inc., a leading biotechnology company headquartered in California, has been at the forefront of immuno-oncology since its establishment in 1998. With a strong presence in North America and Israel, Compugen focuses on the discovery and development of novel therapeutic agents that harness the immune system to combat cancer. The company is renowned for its innovative approach to drug development, particularly its unique computational biology platform that identifies new immune checkpoints and therapeutic targets. Compugen's core products include monoclonal antibodies and immune-modulating therapies, which have shown promise in clinical trials. Recognised for its significant contributions to the field, Compugen has achieved notable milestones, including strategic partnerships with major pharmaceutical companies, solidifying its position as a key player in the biotechnology industry.
DitchCarbon Score
How does Compugen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Compugen, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Compugen, Inc.'s reported carbon emissions
Compugen, Inc., headquartered in California, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Compugen may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without emissions data or reduction initiatives, it is unclear how Compugen aligns with broader industry efforts to combat climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Compugen, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
